Glycopeptide antibiotic resistance

Annual Review of Pharmacology and Toxicology

Volumn 42, Issue , 2002, Pages 381-408

  Pootoolal, Jeff ^a   Neu, John ^a   Wright, Gerard D ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Teicoplanin; VanA; VanB; VanC; Vancomycin

Indexed keywords

GLYCOPEPTIDE; GLYCOPEPTIDE ANTIBIOTIC AGENT; REGULATOR PROTEIN; TEICOPLANIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL CELL WALL; DRUG MECHANISM; DRUG STRUCTURE; ENTEROCOCCUS; GENE EXPRESSION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STAPHYLOCOCCUS; STREPTOCOCCUS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; GLYCOPEPTIDES; STAPHYLOCOCCUS; STREPTOCOCCUS; VANCOMYCIN RESISTANCE;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS; POSIBACTERIA; STAPHYLOCOCCUS; STREPTOCOCCUS;

EID: 0036174606     PISSN: 03621642     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pharmtox.42.091601.142813     Document Type: Review

References (116)

1. Historical yearly usage of vancomycin
2. Modifications of the acyl-D-alanyl-D-alanine terminus affecting complex-formation with vancomycin
3. Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala
4. Glycopeptide antibiotic activity and the possible role of dimerization: A model for biological signalling
5. Dimerization and membrane anchors in extracellular targeting of vancomycin group antibiotics
6. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium
7. Symposium on antimicrobial agents - Part XII. Vancomycin
8. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147
9. Molecular basis for vancomycin resistance in Enterococcusfaecium BM4147: Biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA
10. A thioredoxin fusion protein of VanH, a D-lactate dehydrogenase from Enterococcus faecium: Cloning, expression, purification, kinetic analysis, and crystallization
11. Insights into substrate binding by D-2-ketoacid dehydrogenases from the structure of Lactobacillus pentosus D-lactate dehydrogenase
12. Molecular mechanism of VanHst, an α-ketoacid dehydrogenase required for glycopeptide antibiotic resistance from a glycopeptide producing organism
13. Identification of vancomycin resistance protein VanA as a D-alanine:D-alanine ligase of altered substrate specificity
14. Intracellular steps of bacterial cell wall peptidoglycan biosynthesis: Enzymology, antibiotics, and antibiotic resistance
15. The molecular basis of vancomycin resistance in clinically relevant Enterococci: Crystal structure of D-alanyl-D-lactate ligase (VanA)
16. Vancomycin resistance: Structure of D-alanine:D-alanine ligase at 2.3 Å resolution
17. Gain of D-alanyl-D-lactate or D-lactyl-D-alanine synthetase activities in three activestite mutants of the Escherichia coli D-alamyl-D-alanine ligase B
18. Calculation of the pKa values for the ligands and side chains of Escherichia coli D-alanine:D-alanine ligase
19. D-Alanyl-D-lactate and D-alanyl-D-alanine synthesis by D-alanyl-D-alanine ligase from vancomycin-resistant Leuconostoc mesenteroides. Effects of a phenylalanine 261 to tyrosine mutation
20. Determinants for differential effects on D-Ala-D-lactate vs D-Ala-DAla formation by the VanA ligase from vancomycin-resistant enterococci
21. Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine
22. Overexpression, purification, and characterization of VanX, a D-, D-dipeptidase which is essential for vancomycin resistance in Enterococcus faecium BM4147
23. The structure of VanX reveals a novel aminodipeptidase involved in mediating transposonbased vancomycin resistance
24. Sequence of the vanY gene required for production of a vancomycin-inducible D,D-carboxypeptidase in Enterococcus faecium BM4147
25. Characterization of vanY, a DD-carboxypeptidase from vancomycin-resistant Enterococcus faecium BM4147
26. Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci
27. Requirement of the VanY and VanX D,D-peptidases for glycopeptide resistance in enterococci
28. Identification and characterization of IS1476, an insertion sequencelike element that disrupts VanY function in a vancomycin-resistant Enterococcus faecium strain
29. The vanZ gene of Tn1546 from Enterococcus faecium BM4147 confers resistance to teicoplanin
30. The vanB gene of vancomycin-resistant Enterococcus faecalis V583 is structurally related to genes encoding D-Ala: D-Ala ligases and glycopeptide-resistance proteins VanA and VanC
31. Purification and characterization of the VanB ligase associated with type B vancomycin resistance in Enterococcusfaecalis V583
32. Regulation of VanB-type vancomycin resistance gene expression by the VanS(B)-VanR(B) two-component regulatory system in Enterococcus faecalis V583
33. Characterization of transposon Tn1549, conferring VanB-type resistance in Enterococcus spp.
34. Conjugal transfer of the vancomycin resistance determinant vanB between enterococci involves the movement of large genetic elements from chromosome to chromosome
35. Sequence of the vanC gene of Enterococcus gallinarum BM4174 encoding a D-alanine:D-alanine ligase-related protein necessary for vancomycin resistance
36. Analysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens
37. Analysis of peptidoglycan precursors in vancomycin-resistant Enterococcus gallinarum BM4174
38. Bacterial resistance to vancomycin: Overproduction, purification, and characterization of VanC2 from Enterococcus casseliflavus as a D-Ala-D-Ser ligase
39. D-Ala-D-X ligases: Evaluation of D-alanyl phosphate intermediate by MIX, PIX and rapid quench studies
40. Association constants for the binding of vancomycin and teicoplanin to N-acetyl-D-alanyl-Dalanine and N-acetyl-D-alanyl-D-serine
41. vanC cluster of vancomycin-resistant Enterococcus gallinarum BM4174
42. c encodes D,D-dipeptidase (VanX) and D,D-carboxypeptidase (VanY) activities in vancomycin-resistant Enterococcus gallinarum BM4174
43. Characterization and modelling of VanT: A novel, membrane-bound, serine racemase from vancomycin-resistant Enterococcus gallinarum BM4174
44. Serine and alanine racemase activities of VanT: A protein necessary for vancomycin resistance in Enterococcus gallinarum BM4174
45. Inducible and constitutive expression of vanC-1-encoded resistance to vancomycin in Enterococcus gallinarum
46. VanD-type glycopeptide-resistant Enterococcus faecium BM4339
47. Characterization of the vanD glycopeptide resistance gene cluster from Enterococcus faecium BM4339
48. Vancomycin dependence in a vanA-producing Enterococcus avium strain with a nonsense mutation in the natural D-Ala-D-Ala ligase gene
49. Vancomycin-dependent Enterococcus faecalis clinical isolates and revertant mutants
50. Molecular characterization of the vanD gene cluster and a novel insertion element in a vancomycinresistant enterococcus isolated in Canada
51. VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405
52. Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis
53. Staphylococcus aureus infections
54. Co-transfer of vancomycin and other resistance genes from Enterococcusfaecalis NCTC 12201 to Staphylococcus aureus
55. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
56. Staphylococcus aureus with reduced susceptibility to vancomycin-United States, 1997
57. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital
58. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus
59. Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus
60. Suppression of glycopeptide resistance in a highly teicoplanin-resistant mutant of Staphylococcus aureus by transposon inactivation of genes involved in cell wall synthesis
61. Characterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds
62. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci
63. Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50
64. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50
65. Gradual alterations in cell wall structure and metabolism in vancomycin-resistant mutants of Staphylococcus aureus
66. Inactivated pbp4 in highly glycopeptide-resistant laboratory mutants of Staphylococcus aureus
67. Emergence of vancomycin resistance in the genus Streptococcus: Characterization of a vanB transferable determinant in Streptococcus bovis
68. Isolation of glycopeptide resistant Streptococcus gallolyticus strains with vanA, vanB, and both vanA and vanB genotypes from faecal samples of veal calves in The Netherlands
69. Isolation and characterization of vancomycin-tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis
70. Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin
71. Emergence of vancomycin tolerance in Streptococcus pneumoniae
72. Signal transduction by a death signal peptide: Uncovering the mechanism of bacterial killing by penicillin
73. Modification of peptidoglycan precursors is a common feature of the low-level vancomycin-resistant VANB-type Enterococcus D366 and the naturally glycopeptideresistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroides, and Enterococcus gallinarum
74. Vancomycin-resistant Leuconostoc mesenteroides and Lactobacillus casei synthesize cytoplasmic peptidoglycan precursors that terminate in lactate
75. Analysis of genes encoding D-alanine:D-alaine ligase-related enzymes in Leuconostoc mesenteroides and Lactobacillus spp.
76. Enzymes of vancomycin resistance: The structure of D-alanine-D-lactate ligase of naturally resistant Leuconostoc mesenteroides
77. Vancomycin resistance in enterococci: Reprogramming of the D-ala-D-Ala ligases in bacterial peptidoglycan biosynthesis
78. The biopesticide Paenibacillus popilliae has a vancomycin resistance gene cluster homologous to the enterococcal VanA vancomycin resistance gene cluster
79. D-Ala-D-Ala ligases from glycopeptide antibiotic-producing organisms are highly homologous to the enterococcal vancomycin-resistance ligases VanA and VanB
80. Glycopeptide antibiotic resistance genes in glycopeptideproducing organisms
81. Dd1N from vancomycin-producing Amycolatopsis orientalis C329.2 is a VanA homologue with D-alanyl-D-lactate ligase activity
82. Homologs of the vancomycin resistance D-Ala-D-Ala dipeptidase VanX in Streptomyces toyocaensis, Escherichia coli and Synechocystis: Attributes of catalytic efficiency, stereoselectivity and regulation with implications for function
83. The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147
84. Purification and characterization of VanR and the cytosolic domain of VanS: A two-component regulatory system required for vancomycin resistance in Enterococcus faecium BM4147
85. Identification of the DNA-binding site for the phosphorylated VanR protein required for vancomycin resistance in Enterococcus faecium
86. Transcriptional regulation of the Enterococcus faecium BM4147 vancomycin resistance gene cluster by the VanS-VanR twocomponent regulatory system in Escherichia coli K-12
87. The VanS sensor negatively controls VanR-mediated transcriptional activation of glycopeptide resistance genes of Tn1546 and related elements in the absence of induction
88. In vivo characterization of the type A and B vancomycin-resistant enterococci (VRE) VanRS two-component systems in Escherichia coli: A nonpathogenic model for studying the VRE signal transduction pathways
89. Regulated interactions between partner and non-partner sensors and response regulators that control glycopeptide resistance gene expression in enterococci
90. Specificity of induction of glycopeptide resistance genes in Enterococcus faecalis
91. Induction signals for vancomycin resistance encoded by the vanA gene cluster in Enterococcus faecium
92. A vancomycin-inducible lacZ reporter system in Bacillus subtilis: Induction by antibiotics that inhibit cell wall synthesis and by lysozyme
93. Induction of VanA vancomycin resistance genes in Enterococcus faecalis: Use of a promoter fusion to evaluate glycopeptide and nonglycopeptide induction signals
94. Single-cell analysis of glycopeptide resistance gene expression in teicoplanin-resistant mutants of a VanB-type Enterococcus faecalis
95. Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin
96. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents
97. Comparative in vitro activities of daptomycin and vancomycin against resistant gram-positive pathogens
98. In vivo activities of evernimicin (SCH 27899) against vancomycin-susceptible and vancomycin-resistant enterococci in experimental endocarditis
99. In vitro activity of GAR-936 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae
100. Semisynthetic glycopeptide antibiotics
101. In-vitro and in-vivo antibacterial activity of BI 397, a new semi-synthetic glycopeptide antibiotic
102. Catalysis of carbamate hydrolysis by vancomycin and semisynthetic derivatives
103. Beyond vancomycin: New therapies to meet the challenge of glycopeptide resistance
104. Reductive alkylation of glycopeptide antibiotics: Synthesis and antibacterial activity
105. In vitro activity of the new glycopeptide LY333328 against multiply resistant gram-positive clinical isolates
106. Binding of glycopeptide antibiotics to a model of a vancomycin-resistant bacterium
107. The role of hydrophobic side chains as determinants of antibacterial activity of semisynthetic glycopeptide antibiotics
108. Moderate-level resistance to glycopeptide LY333328 mediated by genes of the vanA and vanB clusters in enterococci
109. The role of hydrophobic substituents in the biological activity of glycopeptide antibiotics
110. Phosphinate analogs of D-,D-dipeptides: Slow-binding inhibition and proteolysis protection of VanX, a D-,D-dipeptidase required for vancomycin resistance in Enterococcus faecium
111. Phosphonamidate and phosphothioate dipeptides as potential inhibitors of VanX
112. Mechanism-based inactivation of VanX, a D-alanyl-D-alanine dipeptidase necessary for vancomycin resistance
113. Continuous assay for VanX, the D-alanyl-D-alanine dipeptidase required for high-level vancomycin resistance
114. Synthesis and evaluation of inhibitors of bacterial D-alanine:D-alanine ligases
115. Histidyl phosphorylation and dephosphorylation of P36 in rat liver extract
116. Restoration of vancomycin susceptibility in Enterococcus faecalis by antirestance determinant gene transfer